CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 820606654
- Phone
- (650) 331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- 8-K Event Unregistered share sale
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Exhibits
Page 6 of 20 · 387 filings